Andrew John Phillips

Insider Reports History

Entity
Individual
Location
C/O Cormorant Asset Management, Llp, 200 Clarendon Street, Fl 52, Boston, MA
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew John Phillips:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 23.4K Feb 13, 2024 Direct
Reneo Pharmaceuticals, Inc. Director Stock Option (right to buy) 15.3K Oct 4, 2024 Direct
MoonLake Immunotherapeutics Director Option to Buy 7.69K Jun 6, 2024 Direct

Insider Reports Filed by Andrew John Phillips

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 1 $0 4 Oct 8, 2024 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Director
MLTX MoonLake Immunotherapeutics Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4/A Feb 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director
MLTX MoonLake Immunotherapeutics Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
MLTX MoonLake Immunotherapeutics Apr 6, 2022 1 $0 4 May 5, 2022 Director
MLTX MoonLake Immunotherapeutics Apr 5, 2022 0 $0 3 Apr 15, 2022 Director